Send me a link:

*Text messaging rates may apply.

 Dow Up 0.01% Nasdaq Down 0.00%

Incyte Corporation (INCY)

-NasdaqGS
48.16 Down 0.82(1.67%) 1:04PM EDT - Nasdaq Real Time Price
Prev Close:48.98
Open:48.48
Bid:48.22 x 100
Ask:48.24 x 100
1y Target Est:71.23
Beta:0.21
Next Earnings Date:31-Jul-14INCY Earnings announcement
Day's Range:47.66 - 48.74
52wk Range:22.51 - 70.86
Volume:459,118
Avg Vol (3m):1,564,090
Market Cap:8.07B
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 1.67%8.07B
AMGNDown 0.01%92.36B
CELGDown 3.77%68.68B
RHHBYUp 1.13%252.91B

Key Statistics

Forward P/E (1 yr):192.92
P/S (ttm):21.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Jun-14) :-0.01
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback